Abl Interactor 1 Binds to Sos and Inhibits Epidermal Growth Factor- and v-Abl-Induced Activation of Extracellular Signal-Regulated Kinases

by Fan, Pang-Dian, Goff, Stephen P.
Published 2000

Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma

by Politi, Katerina, Fan, Pang-Dian, Shen, Ronglai, Zakowski, Maureen, Varmus, Harold
Published 2010

The Thrombopoietin Receptor Can Mediate Proliferation without Activation of the Jak-STAT Pathway

by Dorsch, Marion, Fan, Pang-Dian, Danial, Nika N., Rothman, Paul B., Goff, Stephen P.
Published 1997

Lung adenocarcinomas induced in mice by mutant EGF receptors foundin human lung cancers respondto a tyrosine kinase inhibitor orto down-regulation of the receptors

by Politi, Katerina, Zakowski, Maureen F., Fan, Pang-Dian, Schonfeld, Emily A., Pao, William, Varmus, Harold E.
Published 2006

ERBB3 Independent Activation of the PI3K Pathway in EGFR Mutant Lung Adenocarcinomas

by Song, Xiaoling, Fan, Pang-Dian, Bantikassegn, Amlak, Guha, Udayan, Threadgill, David W., Varmus, Harold, Politi, Katerina
Published in Cancer Res (2015)

Generation of conditional oncogenic chromosomal translocations using CRISPR-Cas9 genomic editing and homology-directed repair

by Spraggon, Lee, Martelotto, Luciano G, Hmeljak, Julija, Hitchman, Tyler D, Wang, Jiang, Wang, Lu, Slotkin, Emily K, Fan, Pang-Dian, Reis-Filho, Jorge S, Ladanyi, Marc
Published in J Pathol (2017)

Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping

by Paik, Paul K., Drilon, Alexander, Fan, Pang-Dian, Yu, Helena, Rekhtman, Natasha, Ginsberg, Michelle S., Borsu, Laetitia, Schultz, Nikolaus, Berger, Michael F., Rudin, Charles M., Ladanyi, Marc
Published in Cancer Discov (2015)

YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics

by Fan, Pang-Dian, Narzisi, Giuseppe, Jayaprakash, Anitha D., Venturini, Elisa, Robine, Nicolas, Smibert, Peter, Germer, Soren, Yu, Helena A., Jordan, Emmet J., Paik, Paul K., Janjigian, Yelena Y., Chaft, Jamie E., Wang, Lu, Jungbluth, Achim A., Middha, Sumit, Spraggon, Lee, Qiao, Huan, Lovly, Christine M., Kris, Mark G., Riely, Gregory J., Politi, Katerina, Varmus, Harold, Ladanyi, Marc
Published in Proc Natl Acad Sci U S A (2018)

SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer

by Pascual, Tomás, Oliveira, Mafalda, Ciruelos, Eva, Bellet Ezquerra, Meritxell, Saura, Cristina, Gavilá, Joaquin, Pernas, Sonia, Muñoz, Montserrat, Vidal, Maria J., Margelí Vila, Mireia, Cejalvo, Juan M., González-Farré, Blanca, Espinosa-Bravo, Martin, Cruz, Josefina, Salvador-Bofill, Francisco Javier, Guerra, Juan Antonio, Luna Barrera, Ana María, Arumi de Dios, Miriam, Esker, Stephen, Fan, Pang-Dian, Martínez-Sáez, Olga, Villacampa, Guillermo, Paré, Laia, Ferrero-Cafiero, Juan M., Villagrasa, Patricia, Prat, Aleix
Published in Front Oncol (2021)